Detalles de la búsqueda
1.
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.
Ann Oncol
; 34(9): 783-795, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302750
2.
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
Ann Oncol
; 32(2): 208-217, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246021
3.
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study.
Ann Oncol
; 30(6): 921-926, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30778520
4.
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Ann Oncol
; 27(3): 379-90, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26681681
5.
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.
Pharmacogenomics J
; 16(5): 472-7, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27378608
6.
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis.
Ann Oncol
; 24(1): 101-8, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23002281
7.
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.
Ann Oncol
; 24(12): 2990-4, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24013581
8.
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.
J Clin Oncol
; 41(23): 3881-3890, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549482
9.
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review.
Cancer Treat Rev
; 114: 102511, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638600
10.
Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials.
ESMO Open
; 7(2): 100433, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35276440
11.
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer.
Br J Cancer
; 104(7): 1079-84, 2011 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-21386839
12.
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Br J Cancer
; 103(7): 1019-24, 2010 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20842128
13.
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial.
Br J Cancer
; 101(2): 232-7, 2009 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-19584872
14.
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.
Ann Oncol
; 20(3): 469-74, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19095777
15.
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges.
J Immunother Cancer
; 7(1): 205, 2019 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31383005
16.
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature.
Int J Gynecol Cancer
; 18(5): 943-53, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18248392
17.
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511].
Cancer Treat Rev
; 119: 102594, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400291
18.
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treatm. Rev. 114 (2023) 102511].
Cancer Treat Rev
; 117: 102570, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37150120
19.
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes.
Eur J Cancer
; 101: 191-200, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30077124
20.
Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?
Cancer Treat Rev
; 60: 100-108, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28942029